Retaglutide and tirzepatide are innovative GLP-1 receptor agonists gaining popularity as effective treatment options for type 2 diabetes. These medications enhance insulin secretion from the pancreas, reduce glucagon https://liviatuuz268331.aboutyoublog.com/48257774/novel-agents-in-diabetes-management